What do we need to be telling our patients about opioids together with acetaminophen?

Robert Hutchison, PharmD, BCACP

doi:10.5055/jom.2014.0196

Authors

Robert Hutchison, PharmD, BCACP

DOI:

https://doi.org/10.5055/jom.2014.0196

Keywords:

opioids, acetaminophen, patients

Author Biography

Robert Hutchison, PharmD, BCACP

Associate Professor, Health Science Center, SRPH Administration Building, Department of Pharmacy Practice, College of Pharmacy, Texas A&M University, College Station, Texas

References

IMS Institute for Healthcare Informatics: Institute_Documents_IHII_UseOfMed_report. Available at www.imshealth.com_imshealth_Global_Content_IMS. Accessed January 28, 2014.

Singla A, Sloan P: Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management. J Opioid Manag. 2013; 9(1): 71-80.

Larson AM, Polson J, Fontana RJ, et al.: Acute Liver Failure Study Group (ALFSG). Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology. 2005; 42: 1364-1372.

Bower WA, Johns M, Margolis HS, et al.: Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007; 102: 2459-2463.

Nourjah P, Ahmad SR, Karwoski C, et al.: Estimates of acetaminophen (Paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 2006; 15: 398-405.

Lai MW, Klein-Schwartz W, Rodgers GC, et al.: 2005 Annual Report of the American Association of Poison Control Centers’ national poisoning and exposure database. Clin Toxicol. 2006; 44: 803-932.

US Food and Drug Administration: Available at http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm381650.htm. Accessed January 28, 2014.